INTRODUCTION: During a time in which SARS-CoV-2 is endemic, it is possible to overlook other causes of acute hypoxemic respiratory failure We present the case of a teenager with a history of anxiety, depression, and PTSD who developed respiratory failure in the spring of 2020 He had recently returned from a wilderness camp in the Southwest United States, where he was exposed to caves, mice, bats, horses, and cows Upon return to the Midwest, he spent the 10 days prior to presentation living in urban parks, where he vaped tobacco and marijuana, and smoked used cigarettes METHODS: The patient was brought to the Emergency Department for 3-4 days of progressive cough and dyspnea On arrival, he was in respiratory failure requiring heated-high flow nasal cannula He was febrile to 39 7 Initial work-up was notable for a white cell count 29,000 with neutrophilia, elevated CRP, procalcitonin and D-dimer Chest xray showed diffuse reticulonodular interstitial pattern Chest CT showed bilateral nodular pleural thickening, peripheral airspace disease and ground glass opacities Antibiotics were initiated for pneumonia Initially, COVID-19 infection was considered the leading diagnosis;however, nasopharyngeal PCRs for SARS-CoV-2 were negative Given the patient's travel, a fungal pneumonia was considered, and fluconazole was started On hospital day 3, he developed worsening respiratory distress on non-invasive ventilation, so he was started on amphotericin and intubated A fungal pneumonia was still favored, but there was also concern for atypical infections, e-cigarette/vaping associated lung injury (EVALI), or other eosinophilic pneumonia He was given methylprednisone 1mg/kg Bronchoscopy demonstrated edematous-friable airways and copious brown-tinged secretions Cultures and immunologic studies were negative for infection BAL fluid notable for 31% eosinophils consistent with idiopathic eosinophilic pneumonia Steroids were continued with rapid improvement, and he was extubated 39 hours later RESULTS: This case highlights the overlapping differential of COVID-19 and other atypical pulmonary infections with EVALI and acute eosinophilic pneumonia in a patient with multiple risk factors A multidisciplinary stepwise approach to diagnosis led to diagnosis and targeted management
Read full abstract